frequent
accompani
gastrointestin
tract
injuri
symptom
ulcer
nausea
vomit
pneumonia
sever
cmvinduc
liver
injuri
character
histolog
small
collect
microabscess
inflammatori
cell
mainli
neutrophil
throughout
hepat
lobul
often
surround
hepatocyt
nuclear
andor
cytoplasm
inclus
socal
owl
eye
inclus
cmv
common
infect
patient
acquir
immunodefici
syndrom
aid
associ
papillari
stenosi
scleros
cholang
aid
cholangiopathi
see
chapter
diagnosi
made
appropri
clinic
context
polymeras
chain
reaction
pcr
test
histolog
evid
infect
infect
usual
defin
primari
patient
evid
prior
exposur
ie
neg
immunoglobulin
ig
g
anticmv
recurr
patient
detect
igg
anticmv
treatment
cmv
infect
alway
indic
immunocompet
patient
unless
infect
sever
life
threaten
mani
immunocompromis
patient
risk
cmv
routin
test
pcr
assay
treat
prophylact
antivir
agent
treatment
viremia
onset
symptom
consid
preemptiv
drug
approv
treatment
cmv
infect
includ
oral
ganciclovir
valganciclovir
intraven
ganciclovir
intraven
foscarnet
intraven
cidofovir
ganciclovirresist
strain
cmv
emerg
choic
durat
treatment
depend
sever
diseas
immun
statu
patient
repeat
assess
cmv
viremia
made
organ
transplant
recipi
risk
cmv
reactiv
usual
receiv
month
prophylact
therapi
transplant
world
popul
serolog
evid
prior
ebv
infect
primari
infect
typic
manifest
infecti
mononucleosi
fever
lymphadenopathi
mild
elev
liver
enzym
level
patient
ebv
mononucleosi
mild
elev
serum
aminotransferas
level
cholestasi
jaundic
report
patient
primari
ebv
infect
casefat
rate
report
immunocompet
immunocompromis
patient
half
death
mononucleosi
rare
attribut
alf
less
case
alf
howev
attribut
ebv
ebvassoci
alf
carri
transplantfre
surviv
monospot
test
detect
heterophil
antibodi
sensit
specif
liver
injuri
attribut
ebv
mononucleosi
diagnos
clinic
combin
symptom
consist
serolog
igm
direct
viral
capsid
antigen
igm
antiebv
vca
definit
sever
ebv
infect
confirm
combin
serolog
evid
viru
pcr
assay
evid
ebvassoci
hepatopatholog
light
microscopi
diffus
sinusoid
lymphocyt
infiltr
without
ebvencod
rna
eber
posit
tissu
stain
treatment
demonstr
efficaci
clinic
trial
lack
acyclovir
inhibit
ebv
vitro
reduc
viral
shed
oropharynx
littl
effect
symptom
ganciclovir
use
support
studi
two
children
ebv
hepat
herp
simplex
viru
two
type
hsv
seropreval
rate
respect
gener
popul
hsv
infect
typic
manifest
orolabi
genit
lesion
rare
present
includ
mening
enceph
hepat
hsv
hepat
usual
occur
neonat
pregnant
women
immunocompromis
patient
patient
associ
mucocutan
involv
mild
asymptomat
elev
serum
aminotransferas
level
seen
patient
acut
hsv
genit
infect
hsv
hepat
rare
approxim
case
report
frequenc
hsv
hepat
cohort
patient
alf
patient
present
fever
leukopenia
elev
serum
aminotransferas
level
prognosi
hsv
hepat
poor
transplantfre
surviv
rate
liver
biopsi
find
consist
hsv
infect
includ
extens
hepatocyt
necrosi
adjac
congest
pauciinflammatori
infiltr
cowdri
type
inclus
bodi
purpl
nuclear
inclus
clear
halo
multinucl
hepatocyt
diagnosi
primari
infect
complic
hepat
made
combin
viremia
detect
pcr
assay
consist
histolog
wherea
reactiv
hepat
occur
serolog
evid
prior
infect
igg
although
prospect
trial
lack
treatment
intraven
acyclovir
mgkg
time
day
may
effect
liver
transplant
consid
patient
meet
criteria
alf
revers
antivir
therapi
dissemin
varicella
infect
typic
present
pneumonia
infrequ
mildli
elev
liver
enzym
level
children
primari
varicella
infect
elev
liver
enzym
report
alf
attribut
vzv
patient
confluenc
vesicular
rash
posit
vzv
pcr
assay
sever
liver
injuri
primari
varicella
infect
organ
transplant
recipi
associ
alf
treatment
hsv
intraven
acyclovir
mgkg
three
time
day
day
adenoviru
doublestrand
dna
viru
frequent
implic
upper
respiratori
tract
ocular
infect
confirm
adenovir
hepat
requir
evid
system
infect
posit
pcr
assay
antigenemia
viral
blood
cultur
liver
biopsi
specimen
consist
viral
infectioneith
stain
adenovir
antigen
diagnost
morpholog
randomli
scatter
punchedout
lesion
larg
nuclei
inclus
consist
waxyappear
dens
materi
unstain
clear
zone
report
case
organ
transplant
recipi
sever
adenovir
hepat
poor
prognosi
low
rate
spontan
recoveri
treatment
may
attempt
cidofovir
influenza
rna
viru
associ
pandem
infect
predomin
respiratori
symptom
mild
asymptomat
elev
liver
enzym
level
common
howev
influenza
directli
infect
hepatocyt
influenza
infect
induc
expans
cell
caus
collater
damag
liver
interact
kupffer
cell
human
herpesviru
rare
caus
liver
injuri
lymphadenopathi
nonspecif
rash
detect
viral
load
posit
pcr
assay
serolog
igm
absenc
potenti
caus
symptom
consid
diagnost
one
studi
suggest
may
respons
nonaeassoci
alf
antigen
isol
liver
tissu
immunohistochemistri
case
virus
uncommon
unit
state
frequent
hepat
involv
chikungunya
rna
viru
associ
epidem
fever
mark
flulik
symptom
arthralgia
earli
phase
infect
day
serum
aminotransferas
level
rang
ul
without
evid
sever
liver
injuri
ie
coagulopathi
jaundic
dengu
viru
common
mosquitoborn
rna
viru
worldwid
highli
preval
tropic
climat
patient
dengu
fever
includ
patient
hemorrhagictyp
fever
present
elev
serum
alanin
aminotransferas
alt
level
without
sever
liver
injuri
mechan
injuri
defin
mortal
rate
associ
sever
hepat
associ
dengu
fever
affect
adult
pediatr
popul
ebola
viru
epidem
rna
viru
associ
hemorrhag
shock
syndrom
independ
shock
patient
present
elev
liver
enzym
level
develop
liver
injuri
index
hospit
serum
aspart
aminotransferas
ast
alt
level
rise
ul
ast
alt
jaundic
develop
patient
cours
infect
mark
elev
alkalin
phosphatas
level
ul
note
american
patient
treat
fatal
frequent
patient
ast
level
ul
sudan
ebola
viru
epidem
uganda
histolog
seri
show
widespread
necrosi
periport
mononuclear
cell
kupffer
cell
hypertrophi
without
promin
bile
duct
damag
liver
injuri
promin
sever
acut
respiratori
syndrom
sar
caus
coronaviru
elev
serum
aminotransferas
level
may
reflect
direct
hepat
injuri
viru
outbreak
sar
asia
case
identifi
